Following vitamin D supplementation, 25-hydroxyvitamin D levels increased modestly (13.3 ng/mL) but hypophosphatemia worsened (2.0 mg/dL), while ALP and PTH levels remained elevated. This evidence concerns the gene PTH and hypophosphatemia.